Skip to main content

Urological oncology

This section considers clinical studies relevant to oncological disorders in urology

Page 2 of 6

  1. Androgen deprivation therapy (ADT) remains a primary treatment for localized prostate cancer (PCa) even though there is no evidence that its use is beneficial in the absence of curative treatment.

    Authors: Heikki Seikkula, Peter J. Boström, Karri Seppä, Janne Pitkäniemi, Nea Malila and Antti Kaipia

    Citation: BMC Urology 2020 20:25

    Content type: Research article

    Published on:

  2. Sarcomatoid differentiation in renal cell carcinoma (RCC) with vena caval tumour thrombus has been shown to be associated with aggressive behaviours and poor prognosis; however, evidence of the impact of rhabd...

    Authors: Bin Yang, Haizhui Xia, Chuxiao Xu, Min Lu, Shudong Zhang, Guoliang Wang and Lulin Ma

    Citation: BMC Urology 2020 20:14

    Content type: Research article

    Published on:

  3. Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopi...

    Authors: Madhusudan Koya, Sue Osborne, Christophe Chemaslé, Sima Porten, Anne Schuckman and Andrew Kennedy-Smith

    Citation: BMC Urology 2020 20:12

    Content type: Research article

    Published on:

  5. Post-operative urinary incontinence is a significant concern for patients choosing to undergo a radical prostatectomy (RP) for treatment of prostate cancer. The aim of our study was to determine the effect of ...

    Authors: Diwei Lin, Michael O’Callaghan, Rowan David, Andrew Fuller, Richard Wells, Peter Sutherland and Darren Foreman

    Citation: BMC Urology 2020 20:8

    Content type: Research article

    Published on:

  6. Preliminary data suggest that the urinary microbiome may play a role in bladder cancer. Information regarding the most suitable method of collecting urine specimens is needed for the large population studies n...

    Authors: Suchitra K. Hourigan, Wei Zhu, Wendy S.W.Wong, Nicole C. Clemency, Marina Provenzano, Thierry Vilboux, John E. Niederhuber, John Deeken, Simon Chung, Kim McDaniel-Wiley and Donald Trump

    Citation: BMC Urology 2020 20:5

    Content type: Research article

    Published on:

  7. Due to their location away from the nerve bundles, anterior prostate cancers (APC) represent a rational target for image-guided cryoablation. This report describes the feasibility and short-term outcomes of an...

    Authors: Christina Sze, Efrat Tsivian, Kae Jack Tay, Ariel A. Schulman, Leah G. Davis, Rajan T. Gupta and Thomas J. Polascik

    Citation: BMC Urology 2019 19:127

    Content type: Research article

    Published on:

  8. Bladder hyperthermic intracavitary chemotherapy (HIVEC) has good effectiveness for bladder cancer, but conventional HIVEC systems lack precision and convenient application. To test the safety of a new HIVEC de...

    Authors: Mingchen Ba, Shuzhong Cui, Hui Long, Yuanfeng Gong, Yinbing Wu, Kunpeng Lin, Yinuo Tu, Bahuo Zhang and Wanbo Wu

    Citation: BMC Urology 2019 19:126

    Content type: Research article

    Published on:

  9. Second-line treatment for urothelial carcinoma (UC) patients is used if progression or failure after platinum-based chemotherapy occurs or if patients are cisplatin-unfit. However, there is still no widely acc...

    Authors: Huitao Wang, Jianhe Liu, Kewei Fang, Changxing Ke, Yongming Jiang, Guang Wang, Tongxin Yang, Tao Chen and Xin Shi

    Citation: BMC Urology 2019 19:125

    Content type: Research article

    Published on:

  10. Advances in systemic targeted therapies afford treatment opportunities in patients with metastatic renal cell carcinoma (RCC). Elderly patients with metastatic RCC present a subpopulation for consideration owi...

    Authors: Christopher S. Hollenbeak, Eric W. Schaefer, Justin Doan and Jay D. Raman

    Citation: BMC Urology 2019 19:123

    Content type: Research article

    Published on:

  11. Predictive models that take race into account like the Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPT RC) and the new Prostate Biopsy Collaborative Group (PBCG) RC have been developed to equitably ...

    Authors: Samuel Carbunaru, Oluwarotimi S. Nettey, Pooja Gogana, Irene B. Helenowski, Borko Jovanovic, Maria Ruden, Courtney M. P. Hollowell, Roohollah Sharifi, Rick A. Kittles, Edward Schaeffer, Peter Gann and Adam B. Murphy

    Citation: BMC Urology 2019 19:121

    Content type: Research article

    Published on:

  13. Metabolic syndrome (MetS) and serum prostate-specific antigen (PSA) levels are correlated. To investigate the underlying effect of MetS on PSA levels, the relationship between the major pathogenic factors of M...

    Authors: Bo-Wen Xia, Si-Cong Zhao, Zong-Ping Chen, Chao Chen, Tian-Shu Liu, Fan Yang and Yong Yan

    Citation: BMC Urology 2019 19:119

    Content type: Research article

    Published on:

  14. Bladder cancer is a complex disease associated with high morbidity and mortality. Management of bladder cancer before radical cystectomy continues to be controversial. We compared the long-term efficacy of one...

    Authors: Wasilijiang Wahafu, Sai Liu, Wenbin Xu, Mengtong Wang, Qingbao He, Liming Song, Mingshuai Wang, Feiya Yang, Lin Hua, Yinong Niu and Nianzeng Xing

    Citation: BMC Urology 2019 19:117

    Content type: Research article

    Published on:

  15. Pelvic floor muscle training (PFM) training for post-prostatectomy incontinence (PPI) is an important rehabilitative approach, but the evidence base is still evolving. We developed a novel PFM training program...

    Authors: Joanne E. Milios, Timothy R. Ackland and Daniel J. Green

    Citation: BMC Urology 2019 19:116

    Content type: Research article

    Published on:

  16. Retzius-sparing robot-assisted laparoscopic radical prostatectomy (rsRARP) allows entire prostatectomy procedure via the pouch of Douglas. In low- and intermediate-risk prostate cancer (PCa) there is level 1 e...

    Authors: Joanne Nyaboe Nyarangi-Dix, Magdalena Görtz, Georgi Gradinarov, Luisa Hofer, Viktoria Schütz, Claudia Gasch, Jan Philipp Radtke and Markus Hohenfellner

    Citation: BMC Urology 2019 19:113

    Content type: Research article

    Published on:

  17. To report a new standardized cognitive fusion technique on transperineal targeted biopsy (TB) of prostate, and to evaluate its efficacy for cancer detection combined with systematic biopsy (SB) .

    Authors: Lei Wang, Xiaofei Wang, Wenfeng Zhao, Zichen Zhao, Zhihu Li, Shengmin Fei, He Zhu, Xiang Ji, Bing Yang, Ningchen Li and Yanqun Na

    Citation: BMC Urology 2019 19:107

    Content type: Research article

    Published on:

  18. Prostate biopsy remains the gold standard approach to verify prostate cancer diagnosis. Transrectal (TR) biopsy is a regular modality, while transperineal (TP) biopsy is an alternative for the patients who dis...

    Authors: Guan-Lin Huang, Chih-Hsiung Kang, Wei-Ching Lee and Po-Hui Chiang

    Citation: BMC Urology 2019 19:101

    Content type: Research article

    Published on:

  19. Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and...

    Authors: C. Senger, A. Conti, A. Kluge, D. Pasemann, M. Kufeld, G. Acker, M. Lukas, A. Grün, G. Kalinauskaite, V. Budach, J. Waiser and C. Stromberger

    Citation: BMC Urology 2019 19:96

    Content type: Research article

    Published on:

  20. Accurate grading at the time of diagnosis if fundamental to risk stratification and treatment decision making in patients with prostate cancer. Whilst previous studies have demonstrated significant pathologica...

    Authors: Nicholas Bullock, Andrew Simpkin, Sarah Fowler, Murali Varma, Howard Kynaston and Krishna Narahari

    Citation: BMC Urology 2019 19:94

    Content type: Research article

    Published on:

  21. Fatigue is one of the most prevalent symptoms among cancer patients. Specifically, in metastatic castration-resistant prostate cancer (mCRPC) patients, fatigue is the most common adverse event associated with ...

    Authors: A. Rodríguez Antolín, L. Martínez-Piñeiro, M. E. Jiménez Romero, J. B. García Ramos, D. López Bellido, J. Muñoz del Toro, A. García García-Porrero and F. Gómez Veiga

    Citation: BMC Urology 2019 19:92

    Content type: Research article

    Published on:

  22. Because of the failure, shortage and related toxicities of Bacillus Calmette-Guérin (BCG), the other intravesical chemotherapy drugs are also widely used in clinical application. Gemcitabine and anthracycline ...

    Authors: Tian-Wei Wang, Hui Yuan, Wen-Li Diao, Rong Yang, Xiao-Zhi Zhao and Hong-Qian Guo

    Citation: BMC Urology 2019 19:90

    Content type: Research article

    Published on:

  23. A variety of penile rehabilitation (PR) therapies are available to improve post-prostatectomy erectile dysfunction (ED) with mixed results. It is uncertain how adherent men are to PR therapies. The aim of this...

    Authors: Jeffrey Albaugh, Brittany Adamic, Cecilia Chang, Nicholas Kirwen and Joshua Aizen

    Citation: BMC Urology 2019 19:89

    Content type: Research article

    Published on:

  24. We investigated the impact of postoperative membranous urethral length and other anatomic characteristics of the pelvic floor shape as measured by magnetic resonance imaging on the improvement in continence fo...

    Authors: Akihiro Nakane, Hiroki Kubota, Yusuke Noda, Tomoki Takeda, Yasuhiko Hirose, Atsushi Okada, Kentaro Mizuno, Noriyasu Kawai, Keiichi Tozawa, Yutaro Hayashi and Takahiro Yasui

    Citation: BMC Urology 2019 19:87

    Content type: Research article

    Published on:

  25. There is an increased incidence of renal cell carcinoma (RCC) in patients with metabolic syndrome who usually have high levels of serum triglyceride (TG) and low high-density lipoprotein-cholesterol (HDL-C). P...

    Authors: Emre Karabay, Nejdet Karsiyakali, Serdar Duvar, Cagatay Tosun, Ahmet Ruknettin Aslan and Omer Ergin Yucebas

    Citation: BMC Urology 2019 19:85

    Content type: Research article

    Published on:

  26. In patients presenting with limited nodal recurrence following radical prostatectomy (RP), stereotactic body radiotherapy (SBRT) results might improve with a better case selection.

    Authors: Christoph Oehler, Michel Zimmermann, Lukas Adam, Juergen Curschmann, Marcin Sumila, Räto T. Strebel, Richard Cathomas, Qiyu Li, Uwe Schneider and Daniel R. Zwahlen

    Citation: BMC Urology 2019 19:84

    Content type: Research article

    Published on:

  27. Perivesical lymph nodes (PVLNs) are occasionally isolated during grossing of cystectomy specimens. However, the prognostic implications of the involvement of PVLNs in bladder cancer patients, especially those ...

    Authors: Meenal Sharma, Takuro Goto, Zhiming Yang and Hiroshi Miyamoto

    Citation: BMC Urology 2019 19:77

    Content type: Research article

    Published on:

  29. Strong evidence comparing effectiveness between nephron-sparing intervention (NSI) and active surveillance (AS) is lacking. Thus, we aim to compare the outcomes of survival, including cancer-specific survival ...

    Authors: Run-Qi Guo and Xiao-Guang Li

    Citation: BMC Urology 2019 19:74

    Content type: Research article

    Published on:

  30. Patient-related factors such as concern about cancer are believed to influence both men’s decisions to undergo prostate specific antigen (PSA) testing and to have definitive treatment if diagnosed with low ris...

    Authors: Kerri Beckmann, Netty Kinsella, Henrik Olsson, Anna Wallerstedt Lantz, Tobias Nordstrom, Markus Aly, Jan Adolfsson, Martin Eklund and Mieke Van Hemelrijck

    Citation: BMC Urology 2019 19:73

    Content type: Research article

    Published on:

  31. Due to the usage of various measurement methods and definitions, comparing continence rates after radical prostatectomy is a challenging task. This study compares continence rates based on different methods an...

    Authors: Sigrun Holze, Meinhard Mende, Karl V. Healy, Norbert Koehler, Lutz Gansera, Michael C. Truss, Udo Rebmann, Stephan Degener and Jens-Uwe Stolzenburg

    Citation: BMC Urology 2019 19:70

    Content type: Research article

    Published on:

  32. The expression level of ribonucleotide reductase subunit M1 (RRM1) is closely related to the effect of gemcitabine-based therapy in advanced bladder cancer. However, the value of RRM1 expression in predicting ...

    Authors: Zhenxing Yang, Bingqiang Fu, Luqiang Zhou, Jie Xu, Ping Hao and Zhenqiang Fang

    Citation: BMC Urology 2019 19:69

    Content type: Research article

    Published on:

  33. Epithelial cell adhesion molecule (EpCAM) expression has been reported in many types of cancer, including prostate cancer (PCa). However, the role of EpCAM expression remains inconsistent. We conducted a meta-...

    Authors: Yu Hu, Qiong Wu, Jialin Gao, Yongrui Zhang and Yuantao Wang

    Citation: BMC Urology 2019 19:67

    Content type: Research article

    Published on:

  34. To evaluate the efficacy of pelvic plexus block (PPB) in relief pain during transperineal template-guided prostate biopsy (TTPB), compared with conventional periprostatic nerve block (PNB).

    Authors: Xue-fei Ding, Tian-bao Huang, Sheng-ming Lu, Hua-zhi Tao, Xiao-fang Ye, Fei Wang, Yao-zong Xu, Jia-nan Xu, Yu-quan Zhou and Yang Luan

    Citation: BMC Urology 2019 19:63

    Content type: Research article

    Published on:

  35. Despite the fact that testicular cancer presents good prognosis, wide variations in mortality rates have been reported internationally. In Brazil, mortality trends and estimates have not been fully assessed. T...

    Authors: Samara Carollyne Mafra Soares, Katarina Márcia Rodrigues dos Santos, Fabia Cheyenne Gomes de Morais Fernandes, Isabelle Ribeiro Barbosa and Dyego Leandro Bezerra de Souza

    Citation: BMC Urology 2019 19:59

    Content type: Research article

    Published on:

  36. There is a change in the position of the remaining anatomical structures of the lower urinary tract system following radical prostatectomy. The aims of this investigation were to describe three novel methods u...

    Authors: Hong Koo Ha, Henk B. Luiting, Petra L. Graham, Manish I. Patel, Jaspreet S. Sandhu, Oguz Akin and Sean F. Mungovan

    Citation: BMC Urology 2019 19:54

    Content type: Technical advance

    Published on:

  37. Let-7 is one of the earliest discovered microRNAs(miRNAs) and has been reported to be down-regulated in multiple malignant tumors. The effects and molecular mechanisms of let-7i in bladder cancer are still unc...

    Authors: M-M Qin, X. Chai, H-B Huang, G. Feng, X-N Li, J. Zhang, R. Zheng, X-C Liu and C. Pu

    Citation: BMC Urology 2019 19:53

    Content type: Research article

    Published on:

  38. Testicular epidermoid cysts (TECs) are rare benign testicular neoplasms. As TECs are rarely associated with germ cell tumours (GCTs), the understanding of biological behaviour and clinical management of TEC is...

    Authors: Petra Anheuser, J. Kranz, E. Stolle, D. Höflmayer, F. Büscheck, S. Mühlstädt, G. Lock and K. P. Dieckmann

    Citation: BMC Urology 2019 19:52

    Content type: Research article

    Published on:

  39. Physicians doubt percutaneous nephrostomy (PCN) insertion on cancer related hydronephrosis patients causes tumor seeding and worse cancer control. In this article, we attempted to determine if preoperative PCN...

    Authors: Guan-Lin Huang, Hao-Lun Luo and Po-Hui Chiang

    Citation: BMC Urology 2019 19:50

    Content type: Research article

    Published on:

  40. Conflicting evidence exists regarding the effect of hypertension on the prognosis of metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). This study aimed to assess t...

    Authors: Yu Liu, Liang Zhou, Yuntian Chen, Banghua Liao, Donghui Ye, Kunjie Wang and Hong Li

    Citation: BMC Urology 2019 19:49

    Content type: Research article

    Published on:

  41. The efficacy of partial nephrectomy (PN) for T1b renal cell carcinoma (RCC) is controversial. The oncological outcomes, the change in postoperative renal function and the perioperative complications are unclear.

    Authors: Yu-Li Jiang, Cheng-Xia Peng, Heng-Zi Wang and Lu-Jie Qian

    Citation: BMC Urology 2019 19:48

    Content type: Research article

    Published on:

  42. The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the mRNA ex...

    Authors: Anika Kremer, Tobias Kremer, Glen Kristiansen and Yuri Tolkach

    Citation: BMC Urology 2019 19:46

    Content type: Research article

    Published on:

  43. Prostate cancer is the most commonly diagnosed cancer in men. Radiotherapy represents one major treatment option in different therapeutic settings. As patients increasingly rely on internet-based medical infor...

    Authors: S. Janssen, F. B. Fahlbusch, L. Käsmann, D. Rades and D. Vordermark

    Citation: BMC Urology 2019 19:42

    Content type: Research article

    Published on:

  44. Intrafascial prostatectomy was a modified technique from the conventional nerve-sparing surgery in order to improve patients’ post-surgical continence and erectile function; however, ongoing controversy exists...

    Authors: Xiao Wang, Yiqi Wu, Jia Guo, Hui Chen, Xiaodong Weng and Xiuheng Liu

    Citation: BMC Urology 2019 19:41

    Content type: Research article

    Published on:

  45. To assess the prognostic value of the extent of positive surgical margins (PSM) following radical prostatectomy (RP) on biochemical recurrence (BR) with long-term follow-up.

    Authors: Yoann Koskas, François Lannes, Nicolas Branger, Sophie Giusiano, Nicolas Guibert, Géraldine Pignot, Jochen Walz, Dominique Rossi and Cyrille Bastide

    Citation: BMC Urology 2019 19:37

    Content type: Research article

    Published on:

  46. In this era of precision medicine, the DNA damage response (DDR) pathway has been shown to be a viable target of intervention in metastatic castration-resistant prostate cancer (CRPC) as approximately one-thir...

    Authors: Isaac E. Kim Jr, Sinae Kim, Arnav Srivastava, Biren Saraiya, Tina Mayer, Wun-Jae Kim and Isaac Yi Kim

    Citation: BMC Urology 2019 19:33

    Content type: Research article

    Published on:

  47. Results from randomized phase III trials have shown that thrice-weekly docetaxel added to androgen-deprivation therapy (ADT) has a significant impact on the survival of patients with metastatic castration-naïv...

    Authors: Sang Eun Yoon, Youjin Kim, Jangho Cho, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byoung Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Su Jin Lee and Se Hoon Park

    Citation: BMC Urology 2019 19:30

    Content type: Research article

    Published on:

  48. There is no criterion for determining whether female patients operated with cystectomy would benefit from hysterectomy. This study compares the oncological outcomes between female patients receiving uterus pre...

    Authors: Haiwen Huang, Bing Yan, Meixia Shang, Libo Liu, Han Hao and Zhijun Xi

    Citation: BMC Urology 2019 19:28

    Content type: Research article

    Published on:

  50. To investigate the prognostic risk factors and postoperative recurrence of bladder cancer in patients with upper urinary tract urothelial carcinomas (UTUCs).

    Authors: Qingwei Wang, Tao Zhang, Junwei Wu, Jianguo Wen, Deshang Tao, Tingxiang Wan and Wen Zhu

    Citation: BMC Urology 2019 19:24

    Content type: Research article

    Published on:

  • New Content Item

  • BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses

Submit manuscript

COVID-19 Announcement

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time. Thank you.

Annual Journal Metrics

Follow

BMC Urology

ISSN: 1471-2490

Contact us